Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results

Aurora Spine Corporation reported record revenues exceeding $5 million for Q4 2025, with total fiscal revenues of $18.4 million, marking a 4.6% increase from the previous year. The company attributed its success to robust product adoption, a strengthened sales force, and new product introductions, including the DEXA offerings for spine surgeries. The gross profit margin improved to 62.4% for Q4, reflecting enhanced sales of higher margin products and effective expense management. CEO Trent Northcutt expressed optimism about ongoing expansion and product development into 2026.